Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2018 Filed Nov 16, 2018 22:14 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 800 | $142.13 | $113,704.00 |
DisclosureSEC source: 0001093557-18-000240 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,105 F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $142.00 to $142.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 14, 2018 Filed Nov 16, 2018 22:14 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 1,200 | $141.25 | $169,500.96 |
DisclosureSEC source: 0001093557-18-000240 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,905 F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $141.00 to $141.42. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,161 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · derivative · entry 8 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,162 Underlying: Common Stock · 11,161 shares Expires 2019-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 2,395 | $148.74 | $356,231.58 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 7 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,837 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $148.32 to $149.09. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 2,766 | $147.99 | $409,337.02 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 6 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,232 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $147.28 to $148.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 2,000 | $146.87 | $293,739.40 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 5 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,998 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $146.22 to $147.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 1,700 | $145.55 | $247,430.07 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 4 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,998 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $145.19 to $146.10. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 500 | $143.00 | $71,500.00 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,698 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 1,800 | $142.25 | $256,045.68 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,198 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $142.00 to $142.71. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:29 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
Exercise / conversionCommon Stock | 11,161 | $4.58 | $51,117.38 |
DisclosureSEC source: 0001093557-18-000238 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:14 UTC |
Murphy Patrick MichaelSVP, GC & Chief Compliance Off
|
SaleCommon Stock | 400 | $148.11 | $59,244.00 |
DisclosureSEC source: 0001093557-18-000236 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,508 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:14 UTC |
ACE HEATHER SSVP Human Resources
|
SaleCommon Stock | 100 | $149.85 | $14,985.00 |
DisclosureSEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 5 ACE HEATHER S · CIK 0001610762 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,081 F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:14 UTC |
ACE HEATHER SSVP Human Resources
|
SaleCommon Stock | 400 | $149.17 | $59,667.00 |
DisclosureSEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 4 ACE HEATHER S · CIK 0001610762 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,181 F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $148.70 to $149.69. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:14 UTC |
ACE HEATHER SSVP Human Resources
|
SaleCommon Stock | 1,000 | $147.87 | $147,871.50 |
DisclosureSEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 3 ACE HEATHER S · CIK 0001610762 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,581 F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $147.56 to $148.48. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:14 UTC |
ACE HEATHER SSVP Human Resources
|
SaleCommon Stock | 1,858 | $147.18 | $273,452.08 |
DisclosureSEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 2 ACE HEATHER S · CIK 0001610762 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,581 F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $146.56 to $147.54. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:14 UTC |
ACE HEATHER SSVP Human Resources
|
SaleCommon Stock | 900 | $145.91 | $131,318.01 |
DisclosureSEC source: 0001093557-18-000235 · edgardoc.xml · nonDerivative · entry 1 ACE HEATHER S · CIK 0001610762 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,439 F1 · shares: On August 30, 2018, Ms. Ace adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Ace. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $145.43 to $146.23. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 54,784 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 10,941 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 13,750 of which were granted on August 22, 2016 and shall vest through August 22, 2020. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:13 UTC |
Abbey DonaldEVP, Quality & Regulatory Afrs
|
SaleCommon Stock | 6,900 | $149.91 | $1,034,361.75 |
DisclosureSEC source: 0001093557-18-000234 · edgardoc.xml · nonDerivative · entry 3 Abbey Donald · CIK 0001534342 · EVP, Quality & Regulatory Afrs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,089 F1 · shares: On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $149.28 to $150.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected F3 · balance_after: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:13 UTC |
Abbey DonaldEVP, Quality & Regulatory Afrs
|
SaleCommon Stock | 1,900 | $148.66 | $282,459.51 |
DisclosureSEC source: 0001093557-18-000234 · edgardoc.xml · nonDerivative · entry 2 Abbey Donald · CIK 0001534342 · EVP, Quality & Regulatory Afrs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,989 F1 · shares: On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $148.22 to $149.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected F3 · balance_after: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:13 UTC |
Abbey DonaldEVP, Quality & Regulatory Afrs
|
SaleCommon Stock | 1,750 | $147.62 | $258,337.98 |
DisclosureSEC source: 0001093557-18-000234 · edgardoc.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · EVP, Quality & Regulatory Afrs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,889 F1 · shares: On September 13, 2018, Mr. Abbey adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Abbey. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $147.22 to $148.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected F3 · balance_after: Included in this number are 70,590 restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 18,333 of which were granted on May 31, 2016 and shall vest through May 31, 2019. Read SEC document |
| October 23, 2018 Filed Oct 26, 2018 00:59 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 100 | $129.78 | $12,978.00 |
DisclosureSEC source: 0001093557-18-000223 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,358 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| October 23, 2018 Filed Oct 26, 2018 00:59 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,636 | $128.66 | $210,487.60 |
DisclosureSEC source: 0001093557-18-000223 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,458 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $128.34 to $129.19. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| October 23, 2018 Filed Oct 26, 2018 00:58 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 1,100 | $129.30 | $142,232.53 |
DisclosureSEC source: 0001093557-18-000222 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,746 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $129.06 to $129.78. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| October 23, 2018 Filed Oct 26, 2018 00:58 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 2,014 | $128.61 | $259,020.94 |
DisclosureSEC source: 0001093557-18-000222 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,846 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $128.06 to $129.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 21:27 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 2,009 | $125.24 | $251,597.72 |
DisclosureSEC source: 0001093557-18-000219 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,105 F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $125.02 to $125.30. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 21:27 UTC |
Balo Andrew KEVP, Reg. Strategy, Clinical
|
SaleCommon Stock | 2,991 | $124.49 | $372,335.83 |
DisclosureSEC source: 0001093557-18-000219 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · EVP, Reg. Strategy, Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,114 F1 · shares: On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $124.00 to $124.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 20:11 UTC |
Murphy Patrick MichaelSVP, GC & Chief Compliance Off
|
SaleCommon Stock | 400 | $122.20 | $48,880.00 |
DisclosureSEC source: 0001093557-18-000217 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,908 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 23:48 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,161 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0001093557-18-000215 · edgardoc.xml · derivative · entry 4 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,323 Underlying: Common Stock · 11,161 shares Expires 2019-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 23:48 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 4,354 | $125.45 | $546,201.46 |
DisclosureSEC source: 0001093557-18-000215 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,837 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $125.00 to $125.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 23:48 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
SaleCommon Stock | 6,807 | $124.32 | $846,231.26 |
DisclosureSEC source: 0001093557-18-000215 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,191 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $124.00 to $124.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 23:48 UTC |
SAYER KEVIN RDirector · President, CEO & Chairman
|
Exercise / conversionCommon Stock | 11,161 | $4.58 | $51,117.38 |
DisclosureSEC source: 0001093557-18-000215 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 136,185 unvested restricted stock units, 80,545 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 40,640 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 15,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:50 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 100 | $140.88 | $14,087.50 |
DisclosureSEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 7 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 55,355 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:50 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 100 | $139.14 | $13,914.00 |
DisclosureSEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 6 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 55,455 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:50 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 300 | $138.08 | $41,422.50 |
DisclosureSEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 5 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 55,555 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $137.80 to $138.24. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:50 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 650 | $137.01 | $89,054.49 |
DisclosureSEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 4 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 55,855 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $136.72 to $137.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:50 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 300 | $135.82 | $40,744.50 |
DisclosureSEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 3 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 56,505 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $135.37 to $136.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:50 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 700 | $133.53 | $93,472.47 |
DisclosureSEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 2 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 56,805 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $133.21 to $133.90. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:50 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 350 | $132.68 | $46,438.49 |
DisclosureSEC source: 0001093557-18-000213 · edgardoc.xml · nonDerivative · entry 1 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 57,505 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $132.14 to $133.06. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 23:10 UTC |
Leach Jacob StevenChief Technology Officer
|
SaleCommon Stock | 24,731 | $144.42 | $3,571,527.37 |
DisclosureSEC source: 0001093557-18-000211 · edgardoc.xml · nonDerivative · entry 3 Leach Jacob Steven · CIK 0001700255 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 0 F1 · shares: On August 23, 2018, the reporting person's spouse adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $144.13 to $144.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 23:10 UTC |
Leach Jacob StevenChief Technology Officer
|
SaleCommon Stock | 13,418 | $143.80 | $1,929,501.69 |
DisclosureSEC source: 0001093557-18-000211 · edgardoc.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 24,731 F1 · shares: On August 23, 2018, the reporting person's spouse adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $143.13 to $144.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 23:10 UTC |
Leach Jacob StevenChief Technology Officer
|
SaleCommon Stock | 9,451 | $142.96 | $1,351,110.23 |
DisclosureSEC source: 0001093557-18-000211 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 38,149 F1 · shares: On August 23, 2018, the reporting person's spouse adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $142.12 to $143.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 220 | $142.49 | $31,348.39 |
DisclosureSEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 5 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 19,094 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $142.23 to $142.74. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 556 | $141.76 | $78,817.00 |
DisclosureSEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 4 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 19,314 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $141.19 to $142.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 820 | $140.84 | $115,491.01 |
DisclosureSEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 3 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 19,870 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $140.14 to $141.10. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 80 | $139.72 | $11,177.80 |
DisclosureSEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 20,690 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $139.11 to $139.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
DOUBLEDAY RICHARDEVP, Chief Commercial Officer
|
SaleCommon Stock | 60 | $138.25 | $8,294.80 |
DisclosureSEC source: 0001093557-18-000209 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 20,770 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $137.92 to $138.90. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 40 | $142.77 | $5,710.60 |
DisclosureSEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 5 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,860 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $142.74 to $142.79. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 984 | $142.17 | $139,896.56 |
DisclosureSEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 4 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,900 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $141.74 to $142.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 1,640 | $141.07 | $231,358.41 |
DisclosureSEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 3 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,884 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $140.71 to $141.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 300 | $140.24 | $42,072.00 |
DisclosureSEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,524 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $139.70 to $140.55. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:32 UTC |
Pacelli Steven RobertEVP, Strategy & Corp. Dev.
|
SaleCommon Stock | 150 | $138.69 | $20,803.50 |
DisclosureSEC source: 0001093557-18-000208 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,824 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $138.53 to $139.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.